Home >> Tag Archives: Cancer Genetics Inc.—

Tag Archives: Cancer Genetics Inc.—

ArcherDx forms NGS partnerships

June 9, 2016—ArcherDx has announced two agreements related to its work in next-generation sequencing. Under terms of an agreement with Illumina, ArcherDx will lead the development of a series of diagnostic tests utilizing ArcherDx’s Anchored Multiplex PCR chemistry that will be run on the Illumina MiSeqDx instrument. This agreement reflects the commitment of both companies to provide NGS-based diagnostics to ...

Read More »